Literature DB >> 10668493

Update from Asia. Asian studies on cancer chemoprevention.

T K Yun1.   

Abstract

In Asia, nontoxic dietary products are considered desirable primary prevention vehicles for conquering cancer. As early as 1978, investigators in Korea carried out extensive long-term anticarcinogenicity experiments using the mouse lung tumor model and observed an anticarcinogenic effect of Panax ginseng C.A. Meyer extract in 1980. The results showed that natural products can provide hope for human cancer prevention. A newly established nine-week medium-term model using mouse lung tumors (Yun's model) could confirm the anticarcinogenicity of ginseng that varies according to its type and age. Subsequently, the ginseng was shown by epidemiological studies to be a nonorgan-specific cancer preventive agent associated with a dose-response relationship. The anticarcinogenic effects of vegetarian foods common at every dining table in Korea and some synthetics were also studied using Yun's nine-week model. In brief, ascorbic acid, soybean lecithin, capsaicin, biochanin A, Ganoderma lucidum, caffeine, and a novel synthetic 2-(allylthio)pyrazine decrease the incidence of mouse lung tumors, whereas fresh ginseng (4 years old), carrot, spinach, Sesamum indicum, beta-carotene, and 13-cis retinoic acid do not. This result regarding beta-carotene is consistent with the ineffective findings of the ATBC trial, the CARET trial, and the Physicians' Health Study. In 1983, a cancer chemoprevention study group was first established in Japan. Subsequently, (-)-epigallocatechin gallate, cryptoporic acid E, and sarcophytol A from natural products, and synthetic acyclic retinoid and canventol were shown to be anticarcinogenic or chemopreventive in human subjects. Despite the frequent consumption of tea wordwide as a beverage and current experimental evidence of anticarcinogenesis, including controversial results of epidemiological studies, more systematic clinical trials for confirmation of preventive activity of tea against cancer are needed. Placebo-controlled intervention trials of dietary fiber are under study in Japan. In the past decade, new triterpenoids were isolated from various natural sources, and its biological activities were investigated in Asia. In the late 1970s a comprehensive chemoprevention program was established at the Institute of Materia Medica, Chinese Academy of Medical Sciences. Since then, many retinoid compounds have been synthesized and screened in the search for chemopreventive cancer agents. The National Cancer Institute (USA) and China are jointly engaged in the two-nutrition intervention in Linxian, China. The results of joint study of the general population and of dysplasia in China should stimulate further research to clarify the potential benefits of micronutrient supplements. We need to clarify if there is a connection between the lower rates of cancer mortality in Korea and the frequent consumption of anticarcinogenic vegetables or traditional foods, including ginseng and Ganoderma lucidum. The constituents of the nontoxic stable dietary products promise to be the future hope for conquering cancers in the coming years.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668493     DOI: 10.1111/j.1749-6632.1999.tb08734.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

1.  Chinese herbal medicines and their efficacy in treating renal stones.

Authors:  Mayur Danny I Gohel; Siu Ping Wong
Journal:  Urol Res       Date:  2006-12

Review 2.  New therapeutic approach for myeloid leukemia: induction of apoptosis via modulation of reactive oxygen species production by natural compounds.

Authors:  Masahiro Kizaki
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

3.  Apoptosis signal-regulating kinase 1-thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis.

Authors:  Kartick C Pramanik; Sanjay K Srivastava
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

4.  Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer.

Authors:  Michelle M Martínez-Montemayor; Raysa Rosario Acevedo; Elisa Otero-Franqui; Luis A Cubano; Suranganie F Dharmawardhane
Journal:  Nutr Cancer       Date:  2011-09-02       Impact factor: 2.900

5.  CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT.

Authors:  Kartick C Pramanik; Neel M Fofaria; Parul Gupta; Sanjay K Srivastava
Journal:  Mol Cancer Ther       Date:  2014-01-13       Impact factor: 6.261

6.  Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats.

Authors:  Kumaraswami Deeptha; Muthaiyan Kamaleeswari; Murugan Sengottuvelan; Namasivayam Nalini
Journal:  Invest New Drugs       Date:  2006-11       Impact factor: 3.850

7.  Generation and analysis of expressed sequence tags from a cDNA library of the fruiting body of Ganoderma lucidum.

Authors:  Hongmei Luo; Chao Sun; Jingyuan Song; Jin Lan; Ying Li; Xiwen Li; Shilin Chen
Journal:  Chin Med       Date:  2010-03-16       Impact factor: 5.455

Review 8.  Discovery of cancer preventive agents from natural products: from plants to prevention.

Authors:  Rajendra G Mehta; John M Pezzuto
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

Review 9.  Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.

Authors:  Lee Jia; Yuqing Zhao; Xing-Jie Liang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Intervention effects of ganoderma lucidum spores on epileptiform discharge hippocampal neurons and expression of neurotrophin-4 and N-cadherin.

Authors:  Shu-Qiu Wang; Xiao-Jie Li; Shaobo Zhou; Di-Xiang Sun; Hui Wang; Peng-Fei Cheng; Xiao-Ru Ma; Lei Liu; Jun-Xing Liu; Fang-Fang Wang; Yan-Feng Liang; Jia-Mei Wu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.